Clinical Trial Update: Alendronate and/or Parathyroid Hormone for Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating alendronate and/or parathyroid hormone for osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)
• alendronate (alendronate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED